| Schedule of Finite-Lived Intangible Assets [Table Text Block] |
Intangible assets at September 30, 2016 and 2015 consist of the following: | | | Useful | | Gross | | Accumulated | | | | | | September 30, 2016 | | Life (years) | | Amount | | Amortization | | Net | | | Acquired Customer Base | | | 5 to 15 | | $ | 718,000 | | $ | 473,000 | | $ | 245,000 | | | Know How | | | 15 | | | 512,000 | | | 282,000 | | | 230,000 | | | Trade Name | | | Indefinite | | | 272,000 | | | - | | | 272,000 | | | Patents | | | 15 | | | 326,000 | | | 6,000 | | | 320,000 | | | Biomedical Technologies | | | 5 | | | 260,000 | | | 260,000 | | | - | | | | | | | | $ | 2,088,000 | | $ | 1,021,000 | | $ | 1,067,000 | | | | | Useful | | Gross | | Accumulated | | | | | | September 30, 2015 | | Life (years) | | Amount | | Amortization | | Net | | | Acquired Customer Base | | | 5 to 15 | | $ | 824,000 | | $ | 464,000 | | $ | 360,000 | | | Know How | | | 15 | | | 512,000 | | | 248,000 | | | 264,000 | | | Trade Name | | | Indefinite | | | 318,000 | | | - | | | 318,000 | | | Patents | | | 15 | | | 223,000 | | | - | | | 223,000 | | | Biomedical Technologies | | | 5 | | | 260,000 | | | 200,000 | | | 60,000 | | | | | | | | $ | 2,137,000 | | $ | 912,000 | | $ | 1,225,000 | |
|
| Schedule of Finite-Lived Intangible Assets, Future Amortization Expense [Table Text Block] |
Estimated amortization expense for each of the next five fiscal years is as follows: | | | 2017 | | 2018 | | 2019 | | 2020 | | 2021 | | Thereafter | | Total | | | Acquired Customer Base | | $ | 80,000 | | $ | 80,000 | | $ | 80,000 | | $ | 5,000 | | $ | - | | $ | - | | $ | 245,000 | | | Know How | | | 34,000 | | | 34,000 | | | 34,000 | | | 34,000 | | | 34,000 | | | 60,000 | | | 230,000 | | | Patents | | | 9,000 | | | 9,000 | | | 9,000 | | | 9,000 | | | 9,000 | | | 80,000 | | | 125,000 | | | | | $ | 123,000 | | $ | 123,000 | | $ | 123,000 | | $ | 48,000 | | $ | 43,000 | | $ | 140,000 | | $ | 600,000 | |
|